Sinopep Jiangsu Inc. was established in April 2009. It is one of the largest enterprises engaged in the R&D and production of peptide. Its main business covers R&D, production and sales of peptide, chemical and biological APIs and drug product as well as peptide for custom design, pharmaceutical intermediates processing and so on.

Sinopep Jiangsu Inc. is located in Economic & Technological Development Area, Lianyungang, Jiangsu, China. It covers an area of 110,000 square meters. The total investment has reached 310 million yuan and it has built two API workshops and two drug product’s workshops, which conform to cGMP standards. The API workshop of peptide has international advanced production line which has passed the US FDA pre-approval inspection, and the solid dosage workshop has passed the GMP inspection of CFDA (China).

The R&D center, equipped with the first-class equipments and instruments, covers an area of 2500 square meters. At present, there are more than 20 products under research in R&D center. Peptide technology reserve center has been built, it has more than 50 peptide technology and has the capacity to supply an order from gram to kilogram. Its product field involves diabetes, cardiocerebral vascular system, anti-tumor, immuno regulation, hepatitis B, assisted reproduction and so on.

Sinopep Jiangsu Inc. has a staff of more than 150 people. There are more than 40 people engaged in research, of which more than 10 people have Master's and doctoral degree and six people have experiences of overseas education.

After years of development, the previous technological achievements are to realize industrialization as a blowout based on the accumulation of technology, product, market, etc. and R&D, new product registration and sales have a good beginning as well. Sinopep Jiangsu Inc. is embarked on a track of rapid development.

To keep good faith and to keep our countenance to develop the pharmaceutical industry .SINOPEP always insists the operation principle of “Strive for the perfection by taking sincerity to service life and health” , forges ahead with determination, makes bold changes and innovations, achieves the new development and new cross of the enterprise continuously. We aim at building a biological pharmaceutical enterprise which comprises of core competition, innovation and high technology, which will lead to a top class enterprise in china and gain popularity overseas. This new development and advancement of the enterprise will be achieved on the basis of innovation and progress

  • Peptides
  • Generic APIs
  • Custom Peptide Synthesis